Final Programme - World Heart Federation
Final Programme - World Heart Federation
Final Programme - World Heart Federation
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Wednesday, 21 May 2008<br />
euPhRates - oChRe Pavillion - 08:30-10:00<br />
Oral abstract session<br />
CaRdiomyoPathies<br />
Chairs: Eduardo Moreyra (ARGENTINA), Hector Delgado Osorio (PUERTO RICO)<br />
08:30 Surgical treatment of primary dilated cardiomyopathy (the role of endomyocardial biopsy analysis)<br />
M. zorc, D. Petroviè, R. Zorc-Pleskoviè, A. Pleskoviè, N. Radovanoviæ<br />
08:43 New insight into the pathogenesis of the hypertrophic cardiomyopathy: benign tumour secreting<br />
inappropriately high amount of BNP during stress<br />
N. Nranyan<br />
08:56 Short and long term follow-up of patients with hypertrophic cardiomyopathy treated with percutaneous<br />
alcohol septal myocardial ablation<br />
L. A. Malek, M. Klopotowski, L. Chojnowska, M. Demkow, A. Witkowski, M. Dabrowski, B. Kusmierczyk, M. Konka,<br />
R. Maczynska, W. Ruzyllo<br />
09:09 Seven years follow-up of metoprolol for treatment of dilated cardiomyopathy<br />
S. Xue<br />
09:22 Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: ultra-Low Dose of Alcohol (1 ml) is<br />
Still Effective<br />
J. Veselka, D. Zemánek, P. Tomašov, R. Duchoňová, K. Linhartová<br />
09:35 Echocardiographic And Pathological Assessment Of Cardiac Myxomas: A 14-year Retrospective Review.<br />
T. F. Cianciulli, L. A. Cosarinsky, J. A. Lax, M. C. Saccheri, J. A. Gagliardi, H. J. Redruello, S. D. Llanos Dethinne,<br />
S. Fandiño Lound, C. E. Parisi, L. A. Vidal<br />
09:48 Value of real-time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy.<br />
Comparison with two-dimensional echocardiography and magnetic resonance imaging.<br />
L. Bicudo, J. Tsutsui, A. Shiozaki, C. Rochitte, E. Arteaga, C. Mady, W. Mathias<br />
missouRi - yelloW Pavillion - 08:30-10:00<br />
Oral abstract session<br />
kidney and heaRt failuRe<br />
Chairs: Daniel Nul (ARGENTINA), Barry Massie (UNITED STATES)<br />
08:30 Kidney-<strong>Heart</strong> Connection: Cardiac Fibrosis and Differential Ventricular Gene Profiles after One Kidney<br />
Nephrectomy in the Absence of <strong>Heart</strong> Failure<br />
F. L. Martin, A. Cataliotti, B. K. Huntley, G. E. Harders, H. H. Chen, J. C. Burnett.<br />
08:45 Experimental Diabetic State Attenuated Left Ventricular Dysfunction after Myocardial Infarction<br />
B. Rodrigues, A. Medeiros, G. Orsi Candido, K. Teodoro Rosa, R. Nitrosi De La Fuente, P. Chakur Brum,<br />
K. De Angelis, M. C. Irigoyen.<br />
09:00 Influence of glomerular filtration rate and age in the accuracy of Brain Natriuretic Peptide<br />
B. Fabricio, L. Armini, J. Kezen, S. Gomes Jr., F. Alvim, P. P. Sampaio, I. Gotlib, J. Mansur.<br />
09:15 High serum adiponectin as a marker of severity and bad prognosis in systolic heart failure<br />
J. Thierer, A. Acosta, N. Vainstein, J. Marino, A. Hirchson Prado, M. Sultan, A. Francesia, M. Sutton, L. Boero, F. Brites.<br />
09:30 Left atrial size and prognosis in patients with heart failure. An individual patient meta-analysis study of<br />
longitudinal data (MeRGE <strong>Heart</strong> Failure)<br />
A. Rossi, M. Quintana, P. L. Temporelli, G. Hillis, N. A. Marsan, D. Prior, C. Yu, K. Poppe, R. Doughty, G. Whalley.<br />
09:45 Comparison of prognostic value of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide<br />
levels in patients with different functional classes of chronic systolic heart failure<br />
A. B. Nargizyan, L. R. Tumasyan, K. G. Adamyan.
Change language